This test is most useful if any of these apply to you.
About 1 in 5 strokes caused by atrial fibrillation are the first time the person learns they have it. The arrhythmia is often silent, comes and goes, and is easy to miss on a single in-office ECG. A wearable that watches your heart all night long has a different advantage: time. It can flag short, irregular runs of beats that suggest AF (atrial fibrillation) even when you feel nothing.
This reading does not diagnose AF. It is a screening signal that tells you the rhythm during sleep looked irregular enough to warrant a real ECG. If your number is anything above zero, the next step is confirmation, not panic. Used this way, the metric works as an early tripwire for an arrhythmia that quietly raises your stroke risk.
Your wearable uses a light-based sensor on your wrist or finger (called PPG, short for photoplethysmography) to track the rhythm of blood pulsing through your vessels. An algorithm scans for the chaotic, irregularly irregular pattern that is the signature of AF. When it sees enough of that pattern, it logs the time as suspected AF. The number you see is the total duration of those episodes during the monitoring window.
Because this is a sleep-window measurement, it captures rhythm during the longest stretch of the day when you are still and your heart rate is at its baseline. AF can occur at any time of day, but the still, low-noise sleep window gives PPG sensors a better chance of producing a clean trace. PPG-based wearables can pick up the irregular pulse pattern that AF produces with high sensitivity, but the signal still has to be confirmed by an electrical recording (an ECG) before AF is considered diagnosed.
AF makes the upper chambers of your heart quiver instead of pumping cleanly. Blood pools, clots form, and clots can travel to the brain. AF is among the most important treatable causes of ischemic stroke, and many people who have a stroke from AF had no prior diagnosis.
Finding AF earlier matters because the standard response (anticoagulation in appropriate candidates, plus rhythm or rate control and risk factor modification) reliably lowers stroke risk. In a large mobile-health study, most participants whose suspected AF was confirmed entered app-supported care, and a high proportion of those at elevated stroke risk were started on anticoagulation.
The clearest payoff of detection is at the brain. Long-term implantable monitoring shows that catching AF gets dramatically more sensitive the longer you watch the heart. A single ten-second ECG snapshot catches roughly 1.5% of episodes, while 30 days of continuous monitoring catches about 34%. A wearable worn nightly over weeks or months gets you closer to the long monitoring window that actually finds intermittent AF.
After a stroke or transient mini-stroke (called a TIA), extended monitoring uncovers previously unknown AF in roughly 11 to 15% of patients, climbing toward 30% with three or more years of implantable monitoring. That is why prolonged rhythm watching is now standard after a stroke of unclear cause.
AF rarely lives alone. It tends to coexist with high blood pressure, diabetes, sleep apnea, obesity, and heart failure, and it accelerates each of those problems. A meta-analysis of more than 447,000 patients with recently diagnosed AF found that starting rhythm-control treatment early cut the combined risk of death, stroke, heart failure, and acute coronary syndrome by 12%, and lowered heart failure hospitalization by 10%.
In other words, finding AF and acting on it does not just prevent stroke. It changes the trajectory of several common cardiovascular outcomes at once, which is why a wearable signal worth confirming is worth confirming quickly.
Wearable algorithms have improved substantially. In a large smartwatch and wristband study using PPG, 0.23% of users got a suspected AF flag, and roughly 87 to 92% of those flags matched true AF on confirmatory ECG or Holter testing, though only a portion of flagged users completed follow-up. Smartphone-based PPG apps in primary care have reported sensitivity around 96% and specificity around 97% against a 12-lead ECG. Home blood pressure monitors with built-in AF algorithms reach a pooled sensitivity of 0.98 and specificity of 0.92.
What this means for you: a wearable flag is not the same as a diagnosis, but it is a strong enough signal that it should never be ignored, especially if you are over 65 or have other heart risk factors. The probability that a true AF episode is behind a positive wearable reading is high, and the consequences of missing it are large.
AF is famously intermittent. Most early AF is paroxysmal, meaning it comes and goes on its own, often for minutes to hours at a time, days or weeks apart. A single negative night tells you very little. A single positive night tells you a confirmatory ECG is needed. The real value of this metric comes from trending nights over weeks and months.
A practical cadence: if your wearable flags suspected AF even once, get a confirmatory ECG promptly. If confirmed, follow the treatment plan and use the wearable to track whether episodes are becoming less frequent. If unconfirmed, keep wearing the device and look for repeat flags, particularly if you have stroke risk factors. Pay attention to changes in flag frequency over time rather than to any single night in isolation.
A confirmed positive wearable flag should trigger a real workup, not a wait-and-see. The first step is a 12-lead ECG or extended ambulatory monitoring (a patch monitor for 1 to 2 weeks, or longer if the suspicion is high). Companion blood work that helps frame the picture includes NT-proBNP (a marker of cardiac strain), hs-CRP (inflammation), thyroid function, and a basic metabolic panel including kidney function, since kidney function shapes anticoagulant choice.
If AF is confirmed, your stroke risk should be formally calculated, anticoagulation should be discussed, and a cardiologist or electrophysiologist should be involved if rhythm control or ablation is on the table. If AF is not confirmed but the wearable keeps flagging, push for longer monitoring. The pattern that should never go unfollowed is a wearable flag plus any of the following: prior stroke or TIA, age over 75, hypertension, diabetes, or heart failure. That combination warrants aggressive workup rather than reassurance.
Evidence-backed interventions that affect your Suspected Atrial Fibrillation level
Suspected Atrial Fibrillation is best interpreted alongside these tests.
Suspected Atrial Fibrillation is included in these pre-built panels.